VHI vs. KSI, DR, FRX, OGI, QIPT, HTL, CPH, CRDL, MDNA, and ACB
Should you be buying Vitalhub stock or one of its competitors? The main competitors of Vitalhub include kneat.com (KSI), Medical Facilities (DR), Fennec Pharmaceuticals (FRX), Organigram (OGI), Quipt Home Medical (QIPT), Hamilton Thorne (HTL), Cipher Pharmaceuticals (CPH), Cardiol Therapeutics (CRDL), Medicenna Therapeutics (MDNA), and Aurora Cannabis (ACB). These companies are all part of the "medical" sector.
kneat.com (TSE:KSI) and Vitalhub (TSE:VHI) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, community ranking, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.
Vitalhub has higher revenue and earnings than kneat.com. kneat.com is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.
Vitalhub has a net margin of 8.66% compared to Vitalhub's net margin of -41.26%. kneat.com's return on equity of 5.78% beat Vitalhub's return on equity.
11.1% of kneat.com shares are owned by institutional investors. Comparatively, 16.9% of Vitalhub shares are owned by institutional investors. 24.7% of kneat.com shares are owned by company insiders. Comparatively, 18.4% of Vitalhub shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Vitalhub received 5 more outperform votes than kneat.com when rated by MarketBeat users. However, 100.00% of users gave kneat.com an outperform vote while only 66.67% of users gave Vitalhub an outperform vote.
In the previous week, kneat.com and kneat.com both had 8 articles in the media. Vitalhub's average media sentiment score of 0.64 beat kneat.com's score of -0.33 indicating that kneat.com is being referred to more favorably in the media.
kneat.com has a beta of 1.01, indicating that its share price is 1% more volatile than the S&P 500. Comparatively, Vitalhub has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500.
Vitalhub has a consensus price target of C$7.25, indicating a potential upside of 1.83%. Given kneat.com's higher possible upside, analysts plainly believe Vitalhub is more favorable than kneat.com.
Summary
Vitalhub beats kneat.com on 12 of the 16 factors compared between the two stocks.
Get Vitalhub News Delivered to You Automatically
Sign up to receive the latest news and ratings for VHI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vitalhub Competitors List
Related Companies and Tools
